Statements (19)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:collaboratesWith |
gptkb:Eli_Lilly
|
gptkbp:focusesOn |
oncology
biosimilars ophthalmology autoimmune diseases innovative biologic drugs |
gptkbp:foundedIn |
2011
|
gptkbp:founder |
gptkb:Michael_Yu
|
gptkbp:headquartersLocation |
gptkb:Suzhou,_China
|
https://www.w3.org/2000/01/rdf-schema#label |
Innovent Biologics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
gptkb:Tyvyt_(sintilimab)
|
gptkbp:numberOfEmployees |
over 4,000
|
gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
|
gptkbp:stockSymbol |
gptkb:01801.HK
|
gptkbp:website |
https://www.innoventbio.com/
|
gptkbp:bfsParent |
gptkb:Zhangjiang
|
gptkbp:bfsLayer |
6
|